Transvaginal Mesh Update

On July 13, 2011, the FDA issued an updated safety communication warning doctors, health care professionals and patients that the placement of surgical mesh through the vagina to treat pelvic organ prolapse may present greater risk for the patient than other options.  This is also called transvaginal mesh, which is a surgically-implanted device that stretches across the vaginal wall to add extra support to damaged tissue.

Thus far, the FDA has received more than 1,000 patients reports regarding complications associated with the use of the mesh.  According to the FDA, reported complications include the mesh becoming exposed or protruding out of the vaginal tissue, pain, infection, organ perforation and urinary problems.  Some cases required additional surgery or hospitalization for treatment or to remove the mesh.

If you or someone you know has had complications from transvaginal mesh, give us a call.  Boyd B. Newton is an Atlanta Product Liability Attorney with understanding and know how.  Visit us online at http://www.injurylawyerofatlanta.com for more information.

Share